Spectral Diagnosis of Cutaneous Malignancy

CompletedOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

November 20, 2018

Study Completion Date

November 20, 2018

Conditions
Skin Cancer
Interventions
DEVICE

Spectral Diagnosis Probe

The device collects two types of tissue spectra: i) laser-induced fluorescence spectra and ii) white light reflectance spectra. This portable reflectance spectrofluorimeter collects spectra in a fraction of a second. Light collection and delivery are achieved via an optical fiber probe. The optical fiber probe is approximately 1 mm in diameter and 3 m long. The same probe collects light emitted from the tissue and delivers it back to the instrument for spectral analysis.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

University of Texas at Austin

OTHER

lead

M.D. Anderson Cancer Center

OTHER

NCT00476905 - Spectral Diagnosis of Cutaneous Malignancy | Biotech Hunter | Biotech Hunter